BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Argula RG, Ward C, Feghali-Bostwick C. Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH). Ther Clin Risk Manag 2019;15:1427-42. [PMID: 31853179 DOI: 10.2147/TCRM.S219024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu Z, Ruan J, Pan L, Chen C. Candidate Genes Identified in Systemic Sclerosis-Related Pulmonary Arterial Hypertension Were Associated with Immunity, Inflammation, and Cytokines. Cardiovasc Ther 2021;2021:6651009. [PMID: 33680092 DOI: 10.1155/2021/6651009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Huang YX, Li F, Liu D, Sun YY, Zhao QH, Jiang R, Wang L, Yuan P, Liu JM, Wu Y, Zhang J. The expression profiling of microRNA in systemic sclerosis-associated pulmonary arterial hypertension. Ann Transl Med 2021;9:1458. [PMID: 34734010 DOI: 10.21037/atm-21-4342] [Reference Citation Analysis]
3 Angeloudi E, Pagkopoulou E, Arvanitaki A, Soulaidopoulos S, Garyfallos A, Kitas G, Dimitroulas T. Cardiovascular Risk in Systemic Sclerosis. Curr Treat Options in Rheum 2020;6:282-98. [DOI: 10.1007/s40674-020-00152-z] [Reference Citation Analysis]
4 Fang X, He C, Ni X, Zhang T, Li Q, Luo Y, Long W, Wu R. A potential model of systemic sclerosis with pulmonary hypertension induced by monocrotaline plus bleomycin. Clin Exp Hypertens 2022;:1-7. [PMID: 35621164 DOI: 10.1080/10641963.2022.2079665] [Reference Citation Analysis]
5 Okamoto S, Kondo Y, Sato K, Nishiyama T, Toko H, Yagishita M, Yokosawa M, Tsuboi H, Ieda M, Matsumoto I. Anti-PL-7 antibody positive antisynthetase syndrome diagnosed after the onset of pulmonary hypertension and right-sided heart failure. Rheumatology (Oxford) 2021;60:e277-9. [PMID: 33576389 DOI: 10.1093/rheumatology/keab142] [Reference Citation Analysis]